Especially given how quickly we are trying to develop a COVID-19 vaccine, it’s a good sign that the AstraZeneca trial paused to investigate an unexplained illness, commented Susan Ellenberg, PhD.

Susan Ellenberg, PhD, comments on the state of COVID-19 vaccine development: She hopes people are reassured by the AstraZeneca trial's pause for safety and says it's unlikely that we’ll have a vaccine this fall.

New COVID-19 infections were about 30 percent lower in counties where the highest number of people stopped going in to their offices for work, found research led by Joshua Baker, MD, MSCE.